Nauck, M.A., D'Alessio, D.A
Zepbound is administered as a once-weekly subcutaneous injection, with dosing initiated at 2.5 mg for 4 weeks, then increased by 2.5 mg every 4 weeks until the target maintenance dose (5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg weekly) is reached, based on individual response and tolerability
Still, they can feel confusing or surprising if you do not know why they are happening
A Personalized Approach to Medical Weight Loss There is no single treatment that should be recommended to every patient
Brain Res Prot 7 : 1120 Garzya G, Corallo D, Fiore A, Lecciso G, Petrelli G, Zotti C